(firstQuint)A Trial to Assess Brexpiprazole Versus Placebo for the Treatment of Acute Manic Episodes Associated With Bipolar I Disorder.

 A multicenter, randomized, double-blind trial of Brexpiprazole versus Placebo for the acute treatment of manic episodes, with or without mixed features, associated with bipolar I disorder.

 This study will also demonstrate the safety and tolerability of brexpiprazole in the study population of males and females aged 18 to 65 years (inclusive, at time of consent).

.

 A Trial to Assess Brexpiprazole Versus Placebo for the Treatment of Acute Manic Episodes Associated With Bipolar I Disorder@highlight

To Demonstrate the Efficacy of Brexpiprazole for the Acute Treatment of Manic Episodes, With or Without Mixed Features, in Subjects with a Diagnosis of Bipolar I Disorder